Twist Bioscience Corporation (HAM:0ME) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Made bigger: US$300M · US$96 a share · Goldman Sachs & Co. LLC +3 Dealers: Goldman Sachs & Co. LLC (co-lead), William Blair (co-lead), Leerink Partners (co-lead), Guggenheim Securities (co-lead) Use of proceeds: Research and development, manufacturing capacity expansion, product offerings, working capital and general corporate purposes | Aug 5, 2026 |